The Ahmed ClearPath glaucoma drainage device has been commercially launched in the United States, New World Medical announced in a press release.
Available in 350 mm2 and 250 mm2 sizes, the implant includes a flexible plate with a contour that conforms to the curvature of the eye and suture fixation points positioned more anteriorly on the device in comparison to other valveless drainage devices, the release said.
It is designed to address tube shunt surgery challenges and comes with an optional pre-threaded ripcord and a 23-gauge needle.
“With the launch of the Ahmed ClearPath, we are excited to offer glaucoma patients another treatment option while making tube shunt surgery more convenient and efficient for surgeons,” Bilal Khan, president of New World Medical, said in the release. “We feel strongly that with every addition to New World Medical’s Ahmed brand, we are bringing effective glaucoma treatments to more patients to help preserve their sight.”